Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Pleural Effusion, Malignant 2Mesothelioma, Malignant 2Breast Neoplasms 2Recurrence 1Rare Malignant Neoplasm 1Pancreatic Neoplasms 1Neuroblastoma 1Neoplasms 1Melanoma 1Lymphoma 1Lymphedema 1Immunoglobulin Light-chain Amyloidosis 1Hereditary Sensory and Autonomic Neuropathies 1Head and Neck Neoplasms 1Gynecological Cancers 1Fibrosis 1Fallopian Tube Neoplasms 1Dysplastic Nevus Syndrome 1Complicated Adrenal Tumor Diseases 1Central Nervous System Neoplasms 1Carcinoma, Ovarian Epithelial 1BRAF V600 Colorectal Cancer 1Anxiety Disorders 1

Interventions

Cognitive Behavioral Therapy 4Psilocybin 3Therapeutics 2Oxygen 2Music Therapy 2Methods 2Waiting Lists 1Transurethral Resection of Prostate 1Touch 1Thyroidectomy 1TEMPO 1Surveys and Questionnaires 1Standard of Care 1Sertraline 1Selective Serotonin Reuptake Inhibitors 1Respiration 1Referral and Consultation 1Psychotherapy 1Pharmaceutical Preparations 1Paramedics 1Palliative Care 1Niacin 1Midazolam 1Methylphenidate 1Melatonin 1Ketamine 1Injections 1Hypnosis 1Glutamyl Aminopeptidase 1Fluoxetine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Anxiety Disorders × Pharmaceutical Preparations × Clear all
NCT07174947 2026-03-24

SSRI Antidepressant Fluoxetine Improving Immunotherapy Efficacy in Advanced Hepatobiliary Malignancy Patients With Depression and Anxiety

First Affiliated Hospital of Wenzhou Medical University

Phase 2 Recruiting
240 enrolled

Anxiety Disorders

Data powered by HemOnc (CC BY 4.0) Colophon âš¡